Delivery Order SPE2DB20D1100-SPE2DB24FA8B3

Award Date 3/19/24
Potential Completion Date 3/20/24
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $2,149.48 contract is for the delivery of 4,564,113,042 units of Venlafaxine HCl ER 150 mg capsules. The award has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,023.24, is for the supply of 4,565,638,399 units of the medication venlafaxine HCL ER 37.5 mg capsules. The award has an ultimate completion date of September 3, 2024. Amerisourcebergen, through its Corporate Office Division, has been a significant provider of pharmaceutical and medical products to various federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,162.00 firm fixed-price contract is for the supply of 500 units of Venlafaxine HCL ER 75 MG capsules. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,473.42, is for the delivery of Venlafaxine HCL ER 75 mg capsules. This is a firm fixed price delivery order contract with a completion date of May 10, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The...
This federal contract award, with ID SPE2DX15D3109|SPE2DX24FXVTM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,728.39 firm fixed-price delivery order is for the supply of 1,000 units of the medication Venlafaxine HCl ER 75 mg capsules. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of venlafaxine hydrochloride extended-release 75 mg capsules, with a total potential value of $2,332.91 and a period of performance through October 27, 2023. The contract is a firm-fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,661.53, is for the supply of 4566625013 - Venlafaxine HCL ER 37.5 MG Capsules, 90-count, with a period of performance through December 6, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a larger $999,999,999...
This federal contract award (SPE2DB20D1100|SPE2DB25FY54C) was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566110668 Venlafaxine HCL ER 75 MG Capsules in quantities of 90s. The contract has a ceiling value of $1,018.40 and is a firm fixed price delivery order contract, with an ultimate completion date of October 16, 2024. This contract is not associated with any set-aside program. Amerisourcebergen Drug Corp's...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $84,900 to Amerisourcebergen Drug Corporation for the supply of 4561412098 venlafaxine hydrochloride extended release 150 mg capsules. Under the terms of the order, Amerisourcebergen will deliver 90 count bottles of the medication to a location in Conshohocken, Pennsylvania by July 6, 2023. The funding agency, DLA, utilizes contracts such as this to procure pharmaceuticals in support of the medical readiness of...
This federal contract award is for the delivery of Venlafaxine HCL ER 37.5 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $5,585.89, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 23, 2024. The contract has a completion date of February 26, 2024 and is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor for this award and does not have any listed...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA8B3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,010,710 units of the pharmaceutical drug Venlafaxine HCL ER 75 mg capsules. The $1,864.74 contract has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order was not subject to any set-aside designation.

Generated 6/18/24, 2:21 PM